Business Context and Reporting Period
Company: DaVita Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 11, 2004
Reporting Period: Quarter and fiscal year ended December 31, 2003.
This filing serves as a disclosure of results of operations and financial condition, referencing a press release (Exhibit 99.1) that details the company's financial performance for the specified period.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1), which is not included in the provided text.
The company reports the following non-GAAP financial measures to supplement GAAP results:
- Net earnings excluding refinancing charges and Medicare lab recoveries.
- Operating income excluding Medicare lab recoveries, depreciation, amortization, and minority interest.
- Operating cash flows and free cash flows excluding Medicare lab recoveries collected in the period.
- Revenue excluding Medicare lab recoveries.
Reconciliations between these non-GAAP measures and GAAP measures are included in the referenced press release.
Material Changes
The filing text does not explicitly state material changes versus the prior comparable period. It notes that the non-GAAP measures are used to provide consistency and comparability to prior periods where similar measures were reported, but specific comparative data is absent from this document.
Guidance, Outlook, and Risks
Forward-Looking Statements: The attached press release contains forward-looking statements regarding performance for 2004. The company explicitly states it undertakes no obligation to update these statements based on new information or future events.
Risks and Contingencies: A detailed discussion of factors affecting operating results is referenced in the "Management's Discussion and Analysis" and "Risk Factors" sections of the company's 2002 Form 10-K, 2003 Form 10-Q filings, and the upcoming 2003 Form 10-K (due March 15, 2004).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP financial figures for Q4 and FY 2003.
- Verify the reconciliation of non-GAAP measures to GAAP measures to understand the impact of excluded items (e.g., Medicare lab recoveries, refinancing charges).
- Consult the upcoming Form 10-K for the fiscal year ended December 31, 2003, for a comprehensive risk assessment and detailed MD&A.
- Monitor the company's 2004 performance against the forward-looking statements made in the February 11, 2004 press release, noting the lack of obligation to update them.